DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)

Currently, many human infectious diseases do not developed effective methods of treatment and prevention. One of the latest successes of biotechnology is the use of adenoviral vectors carrying immunodominant antigens  of various pathogens as genetically engineered vaccines  both  preventive and ther...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: L. V. Cherenova, T. V. Kashtigo, Kh. S. Saiadian, M. M. Shmarov
Aineistotyyppi: Artikkeli
Kieli:venäjä
Julkaistu: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2017-08-01
Sarja:Медицинская иммунология
Aiheet:
Linkit:https://www.mimmun.ru/mimmun/article/view/1307
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!